CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,585,993
-62.3%
94,269
-9.8%
0.01%
-53.8%
Q2 2023$9,518,766
+28.2%
104,487
-7.2%
0.01%
+18.2%
Q1 2023$7,427,294
+26.1%
112,603
-1.1%
0.01%
+22.2%
Q4 2022$5,890,234
-21.9%
113,909
+3.2%
0.01%
-30.8%
Q3 2022$7,538,000
+57.8%
110,360
+4.5%
0.01%
+62.5%
Q2 2022$4,776,000
-5.0%
105,614
+6.8%
0.01%
+14.3%
Q1 2022$5,027,000
+2.5%
98,930
-4.6%
0.01%
+16.7%
Q4 2021$4,903,000
+75.8%
103,701
+22.6%
0.01%
+50.0%
Q3 2021$2,789,000
-50.7%
84,617
-5.5%
0.00%
-42.9%
Q2 2021$5,658,000
+45.6%
89,522
-1.1%
0.01%
+40.0%
Q1 2021$3,886,000
-25.2%
90,557
-0.3%
0.01%
-28.6%
Q4 2020$5,195,000
+89.4%
90,830
-0.1%
0.01%
+75.0%
Q3 2020$2,743,000
-7.2%
90,923
+0.4%
0.00%
-20.0%
Q2 2020$2,957,000
+26.9%
90,546
+4.1%
0.01%0.0%
Q1 2020$2,330,000
+2.0%
86,974
+16.6%
0.01%
+25.0%
Q4 2019$2,284,000
+25.8%
74,591
-1.0%
0.00%0.0%
Q3 2019$1,815,000
-3.8%
75,326
+1.2%
0.00%0.0%
Q2 2019$1,886,000
+75.0%
74,417
+34.6%
0.00%
+100.0%
Q1 2019$1,078,000
+44.3%
55,297
-2.4%
0.00%0.0%
Q4 2018$747,000
-24.0%
56,645
+2.5%
0.00%0.0%
Q3 2018$983,000
-19.2%
55,268
-0.0%
0.00%
-33.3%
Q2 2018$1,216,000
+228.6%
55,271
+230.4%
0.00%
+200.0%
Q1 2018$370,0000.0%16,727
-2.0%
0.00%0.0%
Q4 2017$370,00017,0660.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders